Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
AACR Cancer Progress Report provides latest statistics on cancer research and treatment

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Study reveals a new potential treatment approach for glioblastoma

Study reveals a new potential treatment approach for glioblastoma

UTSA researchers study the mechanism of action of Sweet Annie's medicinal compounds

UTSA researchers study the mechanism of action of Sweet Annie's medicinal compounds

‘Like a Russian roulette’: US military firefighters grapple with unknowns of PFAS exposure

‘Like a Russian roulette’: US military firefighters grapple with unknowns of PFAS exposure

Researchers receive $2.5 million award to develop a tailored treatment for glioblastoma

Researchers receive $2.5 million award to develop a tailored treatment for glioblastoma

New research could help improve the effectiveness of immunotherapy for people with brain tumors

New research could help improve the effectiveness of immunotherapy for people with brain tumors

New drug candidate nearly doubles survival for patients with aggressive childhood brain tumors

New drug candidate nearly doubles survival for patients with aggressive childhood brain tumors

Unveiling hidden threats: clustering loops in CAR-T cells impact cancer therapy

Unveiling hidden threats: clustering loops in CAR-T cells impact cancer therapy

Salk scientists find new immunotherapy treatment for glioblastoma

Salk scientists find new immunotherapy treatment for glioblastoma

UTHSC professor receives $2.56 million to continue glioblastoma research

UTHSC professor receives $2.56 million to continue glioblastoma research

Researchers uncover genetic machinery responsible for EBV-induced B cell growth transformation

Researchers uncover genetic machinery responsible for EBV-induced B cell growth transformation

IN8bio opens new cancer research lab in Birmingham's Pepper Place

IN8bio opens new cancer research lab in Birmingham's Pepper Place

Two new compounds can block cancer cell’s escape route

Two new compounds can block cancer cell’s escape route

Henry Ford Health researcher wins grant to study circulating cell-free DNA methylation as a tool for glioma detection

Henry Ford Health researcher wins grant to study circulating cell-free DNA methylation as a tool for glioma detection

Targeting the "don't eat me" signal may improve immunotherapy for glioblastoma

Targeting the "don't eat me" signal may improve immunotherapy for glioblastoma

Elias family's gift to MD Anderson will help advance brain tumor and cancer neuroscience research

Elias family's gift to MD Anderson will help advance brain tumor and cancer neuroscience research

Using a vaccine to boost the response of engineered T cells

Using a vaccine to boost the response of engineered T cells

Research establishes ERβ as a tumor suppressor in inflammatory breast cancer

Research establishes ERβ as a tumor suppressor in inflammatory breast cancer

Ancient retrovirus may be responsible for aggressive brain cancers

Ancient retrovirus may be responsible for aggressive brain cancers

Glioblastoma cells found to have ‘critical point’ between order and disorder

Glioblastoma cells found to have ‘critical point’ between order and disorder

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.